Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (1)
  • AChR
    (1)
  • Adrenergic Receptor
    (1)
  • COX
    (1)
  • Dopamine Receptor
    (1)
  • Drug Metabolite
    (1)
  • P450
    (1)
  • Others
    (7)
Filter
Search Result
Results for "

olanzapine

" in TargetMol Product Catalog
  • Inhibitor Products
    12
    TargetMol | Activity
  • Isotope products
    3
    TargetMol | inventory
Olanzapine
T1567132539-06-1
Olanzapine (LY170053) is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Olanzapine N-Oxide
T28231174794-02-6
Olanzapine N-Oxide is a metabolite of Olanzapine which shows antipsychotic activity.
  • $273
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Olanzapine D3
T12291786686-79-1
Olanzapine D3 is the deuterium labeled Olanzapine.
  • $297
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
Olanzapine Lactam Impurity
T377041017241-34-7
Olanzapine lactam impurity is a potential impurity found in commercial preparations of olanzapine.1It is a degradation product formed by exposure to thermal or oxidative stress. 1.Baertschi, S.W., Brunner, H., Bunnell, C.A., et al.Isolation, identification, and synthesis of two oxidative degradation products of olanzapine (LY170053) in solid oral formulationsJ. Pharm. Sci.97(2)883-892(2008)
  • $615
35 days
Size
QTY
TargetMol | Inhibitor Sale
N-desmethyl Olanzapine
T35716161696-76-0
N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.
  • $35
In Stock
Size
QTY
Olanzapine-d8
TMIJ-03221093380-13-2
Olanzapine-d8 is a deuterated compound of Olanzapine. Olanzapine has a CAS number of 132539-06-1. Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
  • Inquiry Price
20 days
Size
QTY
Olanzapine/Samidorphan
T70964132539-06-1/852626-89-2
Olanzapine/Samidorphan is a combination of olanzapine and the opioid receptor antagonist samidorphan is under development for the treatment of schizophrenia and bipolar I disorder. The single-tablet combination treatment is intended to provide the efficacy of olanzapine while mitigating olanzapine-associated weight gain.
  • $2,720
10-14 weeks
Size
QTY
Olanzapine HCl
T68706783334-36-1
Olanzapine HCl is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine and quetiapine. It is a dopamine antagonist and is classified as a thienobenzodiazepine.
  • $1,520
1-2 weeks
Size
QTY
N-Desmethyl Olanzapine-d8
TMIH-0382786686-82-6
N-Desmethyl Olanzapine-d8 is a deuterated compound of N-Desmethyl Olanzapine.
  • $457
7-10 days
Size
QTY
Olanzapine Thiolactam Impurity
T67386
(Z)-1-(4-(4-Methylpiperazin-1-yl)-2-thioxo-1H-benzo[b][1,4]diazepin-3(2H)-ylidene)propan-2-one is a useful organic compound for research related to life sciences and the catalog number is T67386.
    7-10 days
    Inquiry
    LY-301664
    T19638221176-49-4
    LY-301664 is a compound which has bio-active.
    • $245
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    2-Amino-5-methyl-3-thiophenecarbonitrile
    T1376138564-58-6
    2-Amino-5-methyl-3-thiophenecarbonitrile is commonly used in the synthesis of Olanzapine.
    • $29
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale